Home > Research > Publications & Outputs > Analysis of Leishmania mimetic neoglycoproteins...

Electronic data

  • Barizon de Souza et al accepted version

    Rights statement: https://www.cambridge.org/core/journals/parasitology/article/analysis-of-leishmania-mimetic-neoglycoproteins-for-the-cutaneous-leishmaniasis-diagnosis/101C72EB3721CE2245D73A580D5C17E6 The final, definitive version of this article has been published in the Journal, Parasitology, ? (?), pp ???-??? 2018, © 2018 Cambridge University Press.

    Accepted author manuscript, 959 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Analysis of Leishmania mimetic neoglycoproteins for the cutaneous leishmaniasis diagnosis

Research output: Contribution to journalJournal article

E-pub ahead of print
Close
<mark>Journal publication date</mark>28/05/2018
<mark>Journal</mark>Parasitology
Number of pages11
Publication statusE-pub ahead of print
Early online date28/05/18
Original languageEnglish

Abstract

Oligosaccharides are broadly present on Leishmania cell surfaces. They can be useful for the leishmaniases diagnosis and also helpful in identifying new cell markers for the disease. The disaccharide Galα1-3Galβ is the immunodominant saccharide in Leishmania cell surface and is the unique non-reducing terminal glycosphingolipids structure recognized by anti-α-Gal. This study describes an enzyme-linked immunosorbent assay (ELISA) used to measure serum levels of anti-α-galactosyl (α-Gal) antibodies in patients with cutaneous leishmaniasis (CL). Optimal ELISA conditions were established and two neoglycoproteins (NGP) containing the Galα1-3Gal terminal fraction (Galα1-3Galβ1-4GlcNAc-HAS and Galα1-3Gal-HAS) and one Galα1-3Gal NGP analogue (Galα1-3Galβ1-3GlcNAc-HAS) were used as antigens. Means of anti-α-Gal antibody titres of CL patients were significantly higher (P < 0.05) than the healthy individuals for all NGPs tested. Sensitivity and specificity of all NGPs ranged from 62.2 to 78.4% and 58.3 to 96.7%, respectively. In conclusion, the NGPs can be used for CL diagnosis.

Bibliographic note

https://www.cambridge.org/core/journals/parasitology/article/analysis-of-leishmania-mimetic-neoglycoproteins-for-the-cutaneous-leishmaniasis-diagnosis/101C72EB3721CE2245D73A580D5C17E6 The final, definitive version of this article has been published in the Journal, Parasitology, ? (?), pp ???-??? 2018, © 2018 Cambridge University Press.